Do analysts recommend BHC or APHA?

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, BHC or APHA?

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.53B 0.22 -C$125.65M -C$3.24 N/A Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A

Do analysts prefer PBH or BHC?

Premium Brands presently has a consensus target price of C$118.62, indicating a potential upside of 33.56%. Given Premium Brands' stronger consensus rating and higher probable upside, equities research analysts clearly believe Premium Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer PBH or BHC?

In the previous week, Bausch Health Companies had 2 more articles in the media than Premium Brands. MarketBeat recorded 6 mentions for Bausch Health Companies and 4 mentions for Premium Brands. Bausch Health Companies' average media sentiment score of 2.00 beat Premium Brands' score of 0.15 indicating that Bausch Health Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Premium Brands 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bausch Health Companies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer BHC or AUP?

Given Aurinia Pharmaceuticals' higher probable upside, analysts plainly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend BHC or SLS?

Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts rate BHC or CARA?

Given Cara Operations' higher probable upside, analysts plainly believe Cara Operations is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, BHC or CARA?

Cara Operations has lower revenue, but higher earnings than Bausch Health Companies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.53B 0.22 -C$125.65M -C$3.24 N/A Cara Operations N/A N/A N/A N/A N/A

Bausch Health Companies (BHC) Competitors

C$6.25 -0.03 (-0.48%)

As of 07/24/2026 04:00 PM Eastern

Compare

BHC vs. APHA, PBH, AUP, SLS, and CARA

Should you buy Bausch Health Companies stock or one of its competitors? MarketBeat compares Bausch Health Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Aurinia Pharmaceuticals (AUP), Solaris Resources (SLS), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Bausch Health Companies compare to Aphria?

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APHA) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Aphria	N/A	N/A	N/A

10.7% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

In the previous week, Bausch Health Companies had 6 more articles in the media than Aphria. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 2.00 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Very Positive
Aphria	Neutral

Summary

Bausch Health Companies beats Aphria on 10 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Premium Brands?

Premium Brands (TSE:PBH) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Premium Brands has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premium Brands	C$7.88B	0.59	C$99.56M	C$0.90	98.68
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A

Premium Brands has a net margin of 0.52% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premium Brands	0.52%	2.21%	3.61%
Bausch Health Companies	-13.54%	120.43%	4.16%

Premium Brands has a beta of 0.901611, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.973491, suggesting that its share price is 3% less volatile than the broader market.

Premium Brands presently has a consensus target price of C$118.62, indicating a potential upside of 33.56%. Given Premium Brands' stronger consensus rating and higher probable upside, equities research analysts clearly believe Premium Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

32.5% of Premium Brands shares are held by institutional investors. Comparatively, 10.7% of Bausch Health Companies shares are held by institutional investors. 2.0% of Premium Brands shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Bausch Health Companies had 2 more articles in the media than Premium Brands. MarketBeat recorded 6 mentions for Bausch Health Companies and 4 mentions for Premium Brands. Bausch Health Companies' average media sentiment score of 2.00 beat Premium Brands' score of 0.15 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Premium Brands	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bausch Health Companies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Premium Brands beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks.

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Bausch Health Companies (TSE:BHC) and Aurinia Pharmaceuticals (TSE:AUP) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

Bausch Health Companies has higher revenue and earnings than Aurinia Pharmaceuticals. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A

Given Aurinia Pharmaceuticals' higher probable upside, analysts plainly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Bausch Health Companies had 6 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for Aurinia Pharmaceuticals. Bausch Health Companies' average media sentiment score of 2.00 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Very Positive
Aurinia Pharmaceuticals	Neutral

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Aurinia Pharmaceuticals	N/A	N/A	N/A

10.7% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Bausch Health Companies beats Aurinia Pharmaceuticals on 10 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Solaris Resources?

Bausch Health Companies (TSE:BHC) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Solaris Resources	N/A	60.97%	-51.67%

Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 80.72%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

10.7% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 16.5% of Solaris Resources shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Bausch Health Companies has a beta of 0.973491, meaning that its share price is 3% less volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.777576, meaning that its share price is 78% more volatile than the broader market.

Solaris Resources has lower revenue, but higher earnings than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

In the previous week, Bausch Health Companies had 6 more articles in the media than Solaris Resources. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for Solaris Resources. Bausch Health Companies' average media sentiment score of 2.00 beat Solaris Resources' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Very Positive
Solaris Resources	Neutral

Summary

Solaris Resources beats Bausch Health Companies on 9 of the 15 factors compared between the two stocks.

How does Bausch Health Companies compare to Cara Operations?

Bausch Health Companies (TSE:BHC) and Cara Operations (TSE:CARA) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Cara Operations has lower revenue, but higher earnings than Bausch Health Companies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

In the previous week, Bausch Health Companies had 6 more articles in the media than Cara Operations. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for Cara Operations. Bausch Health Companies' average media sentiment score of 2.00 beat Cara Operations' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Very Positive
Cara Operations	Neutral

10.7% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Given Cara Operations' higher probable upside, analysts plainly believe Cara Operations is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cara Operations has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Cara Operations	N/A	N/A	N/A

Summary

Bausch Health Companies beats Cara Operations on 8 of the 10 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHC vs. The Competition

Export

Metric	Bausch Health Companies	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$2.35B	C$2.25B	C$6.88B	C$12.48B
Dividend Yield	0.76%	2.81%	2.67%	6.19%
P/E Ratio	-1.93	5.00	27.00	36.95
Price / Sales	0.22	1,642.24	492.66	9.44
Price / Cash	7.76	10.18	50.54	82.29
Price / Book	-2.14	9.91	10.28	4.39
Net Income	-C$125.65M	C$20.27B	C$3.60B	C$299.09M
7 Day Performance	-7.82%	-0.87%	-1.25%	0.61%
1 Month Performance	-16.56%	0.08%	-0.35%	1.06%
1 Year Performance	-32.65%	7.16%	18.41%	30.89%

Bausch Health Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHC Bausch Health Companies	0.895 of 5 stars	C$6.25 -0.5%	N/A	-32.4%	C$2.35B	C$10.53B	N/A	19,900	News Coverage Analyst Upgrade Analyst Revision
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.6785 of 5 stars	C$90.30 +1.4%	C$118.62 +31.4%	0.0%	C$4.69B	C$7.88B	100.33	540
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
SLS Solaris Resources	1.4176 of 5 stars	C$10.51 -4.5%	C$19.50 +85.5%	+56.6%	C$1.84B	N/A	N/A	10

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:BHC) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, AUP, SLS, and CARA

How does Bausch Health Companies compare to Aphria?

Summary

How does Bausch Health Companies compare to Premium Brands?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Summary

How does Bausch Health Companies compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, AUP, SLS, and CARA

How does Bausch Health Companies compare to Aphria?

Do analysts recommend BHC or APHA?

Is BHC or APHA more profitable?

Do insiders and institutionals have more ownership in BHC or APHA?

Which has stronger valuation & earnings, BHC or APHA?

Does the media prefer BHC or APHA?

Summary

How does Bausch Health Companies compare to Premium Brands?

Which has better earnings and valuation, PBH or BHC?

Is PBH or BHC more profitable?

Which has more risk & volatility, PBH or BHC?

Do analysts prefer PBH or BHC?

Do institutionals and insiders believe in PBH or BHC?

Does the media prefer PBH or BHC?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Which has higher earnings and valuation, BHC or AUP?

Do analysts prefer BHC or AUP?

Does the media favor BHC or AUP?

Is BHC or AUP more profitable?

Do insiders & institutionals have more ownership in BHC or AUP?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Is BHC or SLS more profitable?

Do analysts recommend BHC or SLS?

Do insiders and institutionals hold more shares of BHC or SLS?

Which has more volatility and risk, BHC or SLS?

Which has better valuation & earnings, BHC or SLS?

Does the media favor BHC or SLS?

Summary

How does Bausch Health Companies compare to Cara Operations?

Which has preferable valuation and earnings, BHC or CARA?

Does the media favor BHC or CARA?

Do insiders and institutionals hold more shares of BHC or CARA?

Do analysts rate BHC or CARA?

Is BHC or CARA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools